Banaszkiewicz, M.; Małyszko, J.; Vesole, D.H.; Woziwodzka, K.; Jurczyszyn, A.; Żórawski, M.; Krzanowski, M.; Małyszko, J.; Batko, K.; Kuźniewski, M.;
et al. New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia. J. Clin. Med. 2019, 8, 1828.
https://doi.org/10.3390/jcm8111828
AMA Style
Banaszkiewicz M, Małyszko J, Vesole DH, Woziwodzka K, Jurczyszyn A, Żórawski M, Krzanowski M, Małyszko J, Batko K, Kuźniewski M,
et al. New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia. Journal of Clinical Medicine. 2019; 8(11):1828.
https://doi.org/10.3390/jcm8111828
Chicago/Turabian Style
Banaszkiewicz, Małgorzata, Jolanta Małyszko, David H. Vesole, Karolina Woziwodzka, Artur Jurczyszyn, Marcin Żórawski, Marcin Krzanowski, Jacek Małyszko, Krzysztof Batko, Marek Kuźniewski,
and et al. 2019. "New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia" Journal of Clinical Medicine 8, no. 11: 1828.
https://doi.org/10.3390/jcm8111828
APA Style
Banaszkiewicz, M., Małyszko, J., Vesole, D. H., Woziwodzka, K., Jurczyszyn, A., Żórawski, M., Krzanowski, M., Małyszko, J., Batko, K., Kuźniewski, M., & Krzanowska, K.
(2019). New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia. Journal of Clinical Medicine, 8(11), 1828.
https://doi.org/10.3390/jcm8111828